NEUROMOLECULAR BASIS FOR PAIN IN SCI AND BURN INJURY

脊髓损伤和烧伤疼痛的神经分子基础

• 批准号: 8181324
• 负责人: Stephen Waxman
• 金额: --
• 依托单位: VA CONNECTICUT HEALTHCARE SYSTEM
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2014-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8181324
• 关键词: Acute; Address; Attenuated; Axon; Burn injury; CCL2 gene; CX3CL1 gene; Cells; Data; Dendritic Spines; Development; Dinoprostone; Etanercept; Figs - dietary; Fractalkine; Frequencies; Goals; Human; Immune; In Vitro; Infiltration; Inflammation; Injury; Interleukin-6; Knock-out; MAPK14 gene; MAPK3 gene; MAPK8 gene; Maintenance; Mediating; Microglia; Minocycline; Mitogen-Activated Protein Kinases; Modeling; Molecular; Morphology; Nerve; Neuroglia; Neuroma; Neurons; Nociception; Pain; Pain management; Pathway interactions; Patients; Peripheral; Peripheral nerve injury; Phenytoin; Pilot Projects; Population; Posterior Horn Cells; Progress Reports; Protein Isoforms; Rattus; Relative (related person); Resistance; Signal Transduction; Signaling Molecule; Site; Spinal Cord; Spinal Ganglia; Spinal cord injury; Spinal cord injury patients; Spinal cord posterior horn; TNF gene; Testing; Therapeutic; Thermal Hyperalgesias; Thick; Time; Traumatic Nerve Injury; Tumor Necrosis Factor-Beta; Tumor Necrosis Factor-alpha; Vertebral column; base; channel blockers; chemokine; chronic pain; cytokine; dorsal horn; effective therapy; ganglion cell; human TNF protein; in vivo; inhibitor/antagonist; injured; macrophage; mechanical allodynia; neuronal excitability; neutrophil; novel; pain behavior; painful neuropathy; prevent; spinal cord injury pain

DESCRIPTION (provided by applicant): PROJECT SUMMARY Chronic pain occurs frequently after burn injury and spinal cord injury (SCI). Currently available treatments are often ineffective or only partially effective. Relatively little is known about the mechanisms responsible for the onset and persistence of pain following burn injury, despite chronic pain being a frequent complaint of burn- injured and SCI patients. Our goal is to identify and characterize cellular and molecular mechanisms that contribute to pain following burn and spinal cord injuries, with the objective of delineating specific targets for more effective pain management. Our recent progress includes development of a burn injury model in rats that produces long-lasting mechanical allodynia associated with hyperexcitability of spinal cord dorsal horn (DH) neurons, and demonstration that pain and DH hyperexcitability occur concomitant with activation of DH microglia, with the spread of pain paralleled by spreading microglial activation in this model. In addition, we have shown that acute early inhibition of microglial activation attenuates burn-induced mechanical allodynia and DH neuronal hyperexcitability. We have also demonstrated that the maintenance of below-level pain following SCI is associated with activation of microglia, and that some microglial functions are regulated by Na channels and can be attenuated with Na channel blockade. Recently, we have also shown that activated polymorphonuclear neutrophils significantly increase excitability of DRG neurons, as manifested by lowered threshold and increased firing frequency. Our preliminary data indicate that macrophages infiltrate DRG following burn injury and SCI, at a time when pain behavior is evident. We have also shown hyperexcitability in DH neurons in vivo in conjunction with activation of DH microglia following burn injury and SCI. We now plan to build upon our progress, via the following specific aims. 1. Elucidate the molecular changes in DRG and DH neurons, and glia, following burn injury, and examine novel pharmacotherapeutic approaches to pain following burn injury. 2. Investigate the effect of Na channel blockade on the activity of microglia following SCI, and determine whether channel blockade can reduce microglial activation and attenuate pain behavior. 3. Examine if infiltration of macrophages into at- and/or below-level DRG is associated with the development and/or persistence of neuropathic pain following SCI. 4. Determine whether Na channel blockade attenuates macrophage infiltration into DRG following SCI and whether neutralizing TNF-a reduce macrophage infiltration into DRG following SCI. 5. Investigate the effects of macrophages and microglia on the excitability of DRG and DH neurons, and determine whether DRG neuron hyperexcitability following activation of these cells can be prevented via neutralization of cytokines which are expressed by immune cells.

描述（由申请人提供）： 项目摘要慢性疼痛经常发生在烧伤和脊髓损伤后（SCI）。当前可用的治疗通常无效或仅部分有效。对于负责烧伤后疼痛发作和持续性的机制，尽管慢性疼痛经常对烧伤和SCI患者的抱怨，但知之甚少。我们的目标是识别和表征细胞和分子机制，这些机制在灼伤和脊髓损伤后导致疼痛，目的是描述更有效的疼痛管理的特定靶标。我们最近的进展包括在大鼠中开发烧伤模型，该模型会产生与脊髓背角（DH）神经元过度兴奋有关的持久机械性异常性疾病，并证明了疼痛和DH过度抗性性与DH微胶质激活同时发生，并随着DH的激活而发生。通过在此模型中扩散小胶质细胞激活与疼痛平行。此外，我们已经表明，急性早期抑制小胶质细胞活化会减弱烧伤引起的机械性异常性疾病和DH神经元过度刺激性。我们还证明，SCI后较低疼痛的维持与小胶质细胞的激活有关，并且某些小胶质细胞功能受NA通道调节，并且可以通过NA通道阻滞来减弱。最近，我们还表明，活化的多形核中性粒细胞显着提高了DRG神经元的兴奋性，这表明阈值降低和发射频率增加。我们的初步数据表明，在明显的疼痛行为时，巨噬细胞在烧伤损伤和SCI后浸润DRG。我们还显示了体内DH神经元的过度兴奋性与烧伤和SCI后DH小胶质细胞的激活结合使用。现在，我们计划通过以下特定目标来建立我们的进步。 1。阐明烧伤损伤后DRG和DH神经元和Glia的分子变化，并检查烧伤后疼痛的新型药物治疗方法。 2。研究NA通道阻滞对SCI后小胶质细胞活性的影响，并确定通道阻滞是否可以减少小胶质细胞激活并减轻疼痛行为。 3。检查巨噬细胞是否渗入AT和/或低于/或低于/或以下的DRG与SCI后神经性疼痛的发育和/或持久性有关。 4。确定NA通道的阻滞在SCI后是否会减弱巨噬细胞渗透到DRG中，以及中和TNF-A是否在SCI后将巨噬细胞浸润减少到DRG中。 5。研究巨噬细胞和小胶质细胞对DRG和DH神经元兴奋性的影响，并确定是否可以通过中和通过中和细胞因子来预防这些细胞的DRG神经元过度兴奋性。